These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 7850812
21. Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma. Pirkmaier A, Dow R, Ganiatsas S, Waring P, Warren K, Thompson A, Hendley J, Germain D. Oncogene; 2003 Jul 10; 22(28):4425-33. PubMed ID: 12853979 [Abstract] [Full Text] [Related]
22. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Bartkova J, Lukas J, Strauss M, Bartek J. Oncogene; 1995 Feb 16; 10(4):775-8. PubMed ID: 7862456 [Abstract] [Full Text] [Related]
23. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3. Geum D, Sun W, Paik SK, Lee CC, Kim K. Mol Reprod Dev; 1997 Apr 16; 46(4):450-8. PubMed ID: 9094091 [Abstract] [Full Text] [Related]
24. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma. Davidson BJ, Lydiatt WM, Abate MP, Schantz SP, Chaganti RS. Head Neck; 1996 Apr 16; 18(6):512-21. PubMed ID: 8902564 [Abstract] [Full Text] [Related]
25. G1-phase regulators, cyclin D1, cyclin D2, and cyclin D3: up-regulation at gastrulation and dynamic expression during neurulation. Wianny F, Real FX, Mummery CL, Van Rooijen M, Lahti J, Samarut J, Savatier P. Dev Dyn; 1998 May 16; 212(1):49-62. PubMed ID: 9603423 [Abstract] [Full Text] [Related]
26. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines. Huang L, Lang D, Geradts J, Obara T, Klein-Szanto AJ, Lynch HT, Ruggeri BA. Mol Carcinog; 1996 Feb 16; 15(2):85-95. PubMed ID: 8599583 [Abstract] [Full Text] [Related]
27. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Jares P, Fernández PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A. Cancer Res; 1994 Sep 01; 54(17):4813-7. PubMed ID: 8062283 [Abstract] [Full Text] [Related]
28. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms. Bui MM, Bagui TK, Boulware DC, Letson DG, Nasir A, Kaiser HE, Pledger WJ, Coppola D. In Vivo; 2007 Sep 01; 21(5):729-37. PubMed ID: 18019405 [Abstract] [Full Text] [Related]
29. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells. Glassford J, Rabin N, Lam EW, Yong KL. Br J Haematol; 2007 Oct 01; 139(2):243-54. PubMed ID: 17897300 [Abstract] [Full Text] [Related]
30. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S, Weinstein IB. Cancer Res; 2002 Jun 15; 62(12):3351-5. PubMed ID: 12067972 [Abstract] [Full Text] [Related]
31. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins. Yu Q, Ciemerych MA, Sicinski P. Oncogene; 2005 Oct 27; 24(47):7114-9. PubMed ID: 16103884 [Abstract] [Full Text] [Related]
32. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL, Sanchez-Beato M, Soler F, Perez-Losada A, Nayach I, Mallofré C, Piris MA, Montserrat E, Cardesa A. Am J Pathol; 1996 May 27; 148(5):1591-600. PubMed ID: 8623927 [Abstract] [Full Text] [Related]
33. Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas. Park HW, Song SY, Lee TJ, Jeong D, Lee TY. Oncol Rep; 2007 Jul 27; 18(1):267-72. PubMed ID: 17549378 [Abstract] [Full Text] [Related]
34. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Nielsen NH, Emdin SO, Cajander J, Landberg G. Oncogene; 1997 Jan 23; 14(3):295-304. PubMed ID: 9018115 [Abstract] [Full Text] [Related]
35. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer. Osman I, Scher H, Zhang ZF, Soos TJ, Hamza R, Eissa S, Khaled H, Koff A, Cordon-Cardo C. Clin Cancer Res; 1997 Dec 23; 3(12 Pt 1):2247-51. PubMed ID: 9815621 [Abstract] [Full Text] [Related]
36. Expression of D-type cyclins in normal and neoplastic rat pituitary. Qian X, Kulig E, Jin L, Lloyd RV. Endocrinology; 1998 Apr 23; 139(4):2058-67. PubMed ID: 9528994 [Abstract] [Full Text] [Related]
37. Amplification and expression of the human cyclin D gene in esophageal cancer. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein IB. Cancer Res; 1992 May 15; 52(10):2980-3. PubMed ID: 1533816 [Abstract] [Full Text] [Related]
38. Alteration of G1/S transition regulators influences recurrences in head and neck squamous carcinomas. Canzonieri V, Barzan L, Franchin G, Vaccher E, Talamini R, Sulfaro S, Baldassarre G. J Cell Physiol; 2012 Jan 15; 227(1):233-8. PubMed ID: 21412768 [Abstract] [Full Text] [Related]
39. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma. Gaffey MJ, Iezzoni JC, Meredith SD, Boyd JC, Stoler MH, Weiss LM, Zukerberg LR, Levine PA, Arnold A, Williams ME. Hum Pathol; 1995 Nov 15; 26(11):1221-6. PubMed ID: 7590696 [Abstract] [Full Text] [Related]
40. Monoclonal antibodies to mammalian D-type G1 cyclins. Vallance SJ, Lee HM, Roussel MF, Shurtleff SA, Kato JY, Strom DK, Sherr CJ. Hybridoma; 1994 Feb 15; 13(1):37-44. PubMed ID: 8200657 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]